Cargando…
COVID-19: The therapeutic landscape
Therapeutics for hospitalized COVID-19 patients were identified through a robust research response with several lessons learned: clinical trial data should guide therapeutic use, results should not be extrapolated between disease stages, and robust studies should be designed to give clinically relev...
Autores principales: | Paules, Catharine I., Fauci, Anthony S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057546/ https://www.ncbi.nlm.nih.gov/pubmed/33899041 http://dx.doi.org/10.1016/j.medj.2021.04.015 |
Ejemplares similares
-
Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward
por: Fauci, Anthony S.
Publicado: (2012) -
Ending the Global HIV Epidemic Begins at the Individual National Level: An Update from the United States
por: Eisinger, Robert W., et al.
Publicado: (2020) -
1138. Optimal Duration of Systemic Corticosteroids Use in COVID-19 Treatment: A Meta-analysis
por: Yu, Nyein, et al.
Publicado: (2022) -
The medicolegal landscape through the lens of COVID-19: time for reform
por: Mehta, Arpan R, et al.
Publicado: (2020) -
Antiviral Therapeutics: Key to Curbing the COVID-19 Pandemic
por: Adashi, Eli Y., et al.
Publicado: (2022)